Trending News
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- This event has passed.
Advances in Gastroenterology and Hepatology
August 26, 2019
The 2020 Advances in Gastroenterology and Hepatolgy conference will shed new light on developments within the gastroenterology and hepatology disciplines. Experts in the field will provide case-based lectures on specific diseases, disorders, and procedures.
On the agenda:
- Small intestinal bacterial overgrowth (SIBO): Current guidelines
- Refractory constipation
- Chronic intestinal pseudo-obstruction
- Endoscopic mucosal resection: Tips and tricks
- Periprocedural management of
antiplatelet/anticoagulation therapy - Endoscopic management of portal hypertension
- Pancreatic cysts
- Management of chronic pancreatitis
- Small bowel bleeding
- Updates in chronic HBV
- Alcoholic liver disease
- Drug induced liver injury
- Current landscape for management of Crohn’s
- Severe IBD: Prevention and management strategies
- Pregnancy in IBD
- Gastroparesis
- Treatment of H. pylori
- Telemedicine in GI
12 AMA PRA Category 1 Credits™ – maximum
12 ABIM MOC points